David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
1376
DELISTED
Premier
PINC
| $7.47M | 0.01% |
197,136
-186,530
| -49% | -$6.56M |
|
1377
Zurn Elkay Water Solutions
ZWS
$8.16B
| $7.45M | 0.01% |
474,117
+20,013
| +4% | +$288K |
|
1378
CALL
Honeywell
HON
$69.9B
| $7.43M | 0.01% |
44,562
-50,291
| -53% | -$8.22M |
|
1379
Oshkosh
OSK
$9.72B
| $7.43M | 0.01% |
78,527
-173,248
| -69% | -$14.9M |
|
1380
Olin
OLN
$2B
| $7.42M | 0.01% |
430,229
-219,051
| -34% | -$3.92M |
|
|
BHVN
1381
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.42M | 0.01% |
136,265
-58,989
| -30% | -$2.92M |
|
1382
HealthStream
HSTM
$841M
| $7.41M | 0.01% |
272,307
+13,968
| +5% | +$384K |
|
|
CSGS
1383
DELISTED
CSG Systems International
CSGS
| $7.38M | 0.01% |
142,632
+7,492
| +6% | +$404K |
|
1384
PUT
Goodyear
GT
$1.8B
| $7.37M | 0.01% |
473,600
-121,200
| -20% | -$1.89M |
|
|
SKX
1385
DELISTED
Skechers
SKX
| $7.37M | 0.01% |
170,526
+152,272
| +834% | +$6.01M |
|
|
I
1386
DELISTED
INTELSAT S. A.
I
| $7.35M | 0.01% |
1,046,053
+959,713
| +1,112% | +$15.1M |
|
|
CRCM
1387
DELISTED
CARE.COM, INC.
CRCM
| $7.35M | 0.01% |
489,267
-88,920
| -15% | -$1.07M |
|
1388
PACCAR
PCAR
$68B
| $7.35M | 0.01% |
139,383
-412,539
| -75% | -$21.2M |
|
1389
Healthcare Services Group
HCSG
$1.57B
| $7.35M | 0.01% |
302,162
-445,524
| -60% | -$11M |
|
|
THS
1390
DELISTED
Treehouse Foods
THS
| $7.35M | 0.01% |
151,489
+38,217
| +34% | +$1.96M |
|
1391
Moderna
MRNA
$59.7B
| $7.34M | 0.01% |
+375,338
| New | +$6.66M |
|
1392
PUT
Vale
VALE
$64.5B
| $7.33M | 0.01% |
555,200
+73,400
| +15% | +$882K |
|
1393
Unisys
UIS
$190M
| $7.32M | 0.01% |
617,247
-190,574
| -24% | -$1.91M |
|
1394
PUT
Domino's
DPZ
$11.4B
| $7.32M | 0.01% |
24,900
-5,200
| -17% | -$1.43M |
|
1395
CALL
Ford
F
$55.4B
| $7.31M | 0.01% |
786,000
-660,000
| -46% | -$5.93M |
|
1396
CMS Energy
CMS
$21.7B
| $7.3M | 0.01% |
116,157
+24,958
| +27% | +$1.56M |
|
1397
Anterix
ATEX
$1.85B
| $7.3M | 0.01% |
168,857
-3,235
| -2% | -$132K |
|
1398
Edgewell Personal Care
EPC
$1.32B
| $7.29M | 0.01% |
235,401
+201,400
| +592% | +$6.5M |
|
1399
PUT
Lowe's Companies
LOW
$118B
| $7.28M | 0.01% |
60,800
-48,800
| -45% | -$5.58M |
|
|
HI
1400
DELISTED
Hillenbrand
HI
| $7.28M | 0.01% |
218,452
-116,646
| -35% | -$3.68M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.